Epigallocatechin-3-Gallate (EGCG) as a potential therapeutic against cardiovascular disease risk in mice | Zendy

AI Assistant Blog Pricing

Open Access

Epigallocatechin-3-Gallate (EGCG) as a potential therapeutic against cardiovascular disease risk in mice

Publication year - 2022

Publication title -

journal of anesthesia and pain medicine

Language(s) - English

Resource type - Journals

ISSN - 2474-9206

DOI - 10.33140/japm.07.03.01

Subject(s) - medicine , analysis of variance , dyslipidemia , coronary artery disease , disease , physiology , blood lipids , diabetes mellitus , endocrinology , cholesterol

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.